Market Research Life Sciences Market Research Healthcare Market Research Facilities Market Research Hospitals & Clinics Market Research

Regenerative Medicine Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologic, Others); By Material (Synthetic Material, Biode

Best Price Guarantee Length Publisher Published Date SKU
from $4,850 240 Pages BlueWeave Consulting January, 2023 BLWC18215437
Best Price Guarantee
Price from $4,850
Length 240 Pages
Publisher BlueWeave Consulting
Published Date January, 2023
SKU BLWC18215437

Regenerative Medicine Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologic, Others); By Material (Synthetic Material, Biodegradable Synthetic Polymer, Scaffold, Others); By Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Others); By End User (Hospitals & Clinics, Commercial Industries, Government & Academic Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Regenerative Medicine Market Size Booming to Reach USD 73.5 Billion by 2029

Global regenerative medicine market is flourishing owing to rising investments in regenerative medicine research, expansion of the regenerative medicine market, and rising prevalence of genetic disorders, cancer, and chronic diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global regenerative medicine market size at USD 12.3 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global regenerative medicine market size to grow at a significant CAGR of 30.2% reaching a value of USD 73.5 billion by 2029. The rise in the prevalence of musculoskeletal diseases, oncological disorders, and dental disorders is the primary factor driving the growth of the regenerative medicine market. Another factor driving the market's expansion is an increase in the use of regenerative medicine products and technological advancements in stem cell-based therapies, which have revolutionized the way researchers view regenerative medicine. Many businesses are increasing their market presence to expand into new markets.

Global Regenerative Medicine Market – Overview

Organs and tissues that have been harmed by disease, aging, or trauma can be repaired, replaced, or regenerate with the help of regenerative medicines. These medicines are used to treat a range of degenerative illnesses, such as orthopedic, cardiovascular, and dermatological conditions. They function by making cells and tissues functional once more. Stem cells are more important in this context because they can divide and differentiate.

Opportunity: Increasing acceptance of cancer immunotherapy products

Normal cells undergo a multi-stage process that typically starts with a precancerous lesion and progresses to malignant tumors before becoming tumor cells, which is how cancer is brought on. The interaction of a person's hereditary factors results in these changes. Cancer is a leading cause of death worldwide, killing about 10 million people. A correct cancer diagnosis is essential for appropriate and efficient treatment because each type of cancer necessitates a different treatment strategy. Surgery, radiotherapy, and chemotherapy are frequently used to treat cancer. Because hematopoietic stem or more developed cells naturally can target and eradicate disease cells, cancer immunotherapy using regenerative medicine has the advantage of being able to do so. It also aids in the development of effective treatments by providing a better understanding of cancer cells. As a result, rising cancer treatment product demand, combined with rising disease prevalence, will create opportunities for market expansion.

Challenge: Costly treatments

For those with serious illnesses and terminal illnesses, gene and cell therapies represent a significant advance in medicine. These treatments are changing how diseases are treated and controlled. Even though these treatments are highly effective at saving lives, demand for them is lower than anticipated. This is due to the expensive nature of these treatments, which is restricting the market growth.

Impact of COVID-19 on Global Regenerative Medicine Market

The COVID-19 pandemic affected nearly all industries in 2020. Different segments of the regenerative medicine market were affected differently by the pandemic. The demand for tissue engineering was negative, whereas the demand for gene therapy was strong due to consistent sales of its rare disease therapeutics. Platelet-Rich Plasma (PRP) demand has decreased.

Global Regenerative Medicine Market – By Material

Global regenerative medicine market is segmented by material into Synthetic Material, Biodegradable Synthetic Polymers, scaffolds, and others. Biodegradable synthetic polymers, scaffolds, materials for artificial vascular grafts, and hydrogels are examples of synthetic material subcategories. The next two types of biologically derived material are collagen and xenogeneic material. Additional types of genetically engineered material include deoxyribonucleic acid, transfection vectors, genetically modified cells, three-dimensional polymer technology, transgenic, fibroblast, neural stem cell, and gene-activated matrices. Pharmaceuticals are divided into two categories: small molecules and biologics.

Competitive Landscape

Global regenerative medicine market is fiercely competitive. Prominent players in the market include Aspect Biosystems, Amgen, Inc., Medtronic plc, AstraZeneca, Novartis AG, Smith & Nephew plc, MiMedx Group, Baxter, 3M, Athersys Inc, Cryo Life Inc, Integra Life Sciences, Isto Biologics, Medtronic Plc, Organogenesis, Stryker Corporation, US Stem Cell Inc, and Zimmer Biomet Holdings Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in global regenerative medicine market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Regenerative Medicine Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Regenerative Medicine Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Regenerative Medicine Market Insights
3.1. Industry Value Chain Analysis
3.1.1. DROC Analysis
3.1.2. Growth Drivers
3.1.2.1. Rise in Prevalence of Musculoskeletal Diseases, Oncological Disorders, and Dental Disorders
3.1.2.2. Rise in Adoption of Regenerative Medicine Products
3.1.2.3. Rise in Monitoring Devices and Surgical Technologies
3.1.3. Restraints
3.1.3.1. Lack of Skilled Professionals
3.1.4. Opportunities
3.1.4.1. Technological Advancement
3.1.4.2. Increasing Investment in Development of Innovative Medicines
3.1.5. Challenges
3.1.5.1. Stringent Regulatory Framework
3.2. Technology Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrants
3.4.4. Threat of Substitutes
3.4.5. Intensity of Rivalry
4. Global Regenerative Medicine Market Overview
4.1. Market Size & Forecast, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Cell Therapy
4.2.1.2. Gene Therapy
4.2.1.3. Tissue Engineering
4.2.1.4. Small Molecule & Biologic
4.2.1.5. Others
4.2.2. By Material
4.2.2.1. Synthetic Material
4.2.2.2. Biodegradable Synthetic Polymer
4.2.2.3. Scaffold
4.2.2.4. Others
4.2.3. By Application
4.2.3.1. Cardiovascular
4.2.3.2. Oncology
4.2.3.3. Dermatology
4.2.3.4. Musculoskeletal
4.2.3.5. Others
4.2.4. By End User
4.2.4.1. Hospitals & Clinics
4.2.4.2. Commercial Industries
4.2.4.3. Government & Academic Research Institutes
4.2.5. By Region
4.2.5.1. North America
4.2.5.2. Europe
4.2.5.3. Asia Pacific (APAC)
4.2.5.4. Latin America
4.2.5.5. Middle East and Africa (MEA)
5. North America Regenerative Medicine Market
5.1. Market Size & Forecast, 2019–2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Material
5.2.3. By Application
5.2.4. By End User
5.2.5. By Country
5.2.5.1. US
5.2.5.1.1. By Product
5.2.5.1.2. By Material
5.2.5.1.3. By Application
5.2.5.1.4. By End User
5.2.5.2. Canada
5.2.5.2.1. By Product
5.2.5.2.2. By Material
5.2.5.2.3. By Application
5.2.5.2.4. By End User
6. Europe Regenerative Medicine Market
6.1. Market Size & Forecast, 2019–2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Material
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.2.5.1. Germany
6.2.5.1.1. By Product
6.2.5.1.2. By Material
6.2.5.1.3. By Application
6.2.5.1.4. By End User
6.2.5.2. UK
6.2.5.2.1. By Product
6.2.5.2.2. By Material
6.2.5.2.3. By Application
6.2.5.2.4. By End User
6.2.5.3. Italy
6.2.5.3.1. By Product
6.2.5.3.2. By Material
6.2.5.3.3. By Application
6.2.5.3.4. By End User
6.2.5.4. France
6.2.5.4.1. By Product
6.2.5.4.2. By Material
6.2.5.4.3. By Application
6.2.5.4.4. By End User
6.2.5.5. Spain
6.2.5.5.1. By Product
6.2.5.5.2. By Material
6.2.5.5.3. By Application
6.2.5.5.4. By End User
6.2.5.6. The Netherlands
6.2.5.6.1. By Product
6.2.5.6.2. By Material
6.2.5.6.3. By Application
6.2.5.6.4. By End User
6.2.5.7. Belgium
6.2.5.7.1. By Product
6.2.5.7.2. By Material
6.2.5.7.3. By Application
6.2.5.7.4. By End User
6.2.5.8. NORDIC Countries
6.2.5.8.1. By Product
6.2.5.8.2. By Material
6.2.5.8.3. By Application
6.2.5.8.4. By End User
6.2.5.9. Rest of Europe
6.2.5.9.1. By Product
6.2.5.9.2. By Material
6.2.5.9.3. By Application
6.2.5.9.4. By End User
7. Asia Pacific Regenerative Medicine Market
7.1. Market Size & Forecast, 2019–2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Material
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.2.5.1. China
7.2.5.1.1. By Product
7.2.5.1.2. By Material
7.2.5.1.3. By Application
7.2.5.1.4. By End User
7.2.5.2. India
7.2.5.2.1. By Product
7.2.5.2.2. By Material
7.2.5.2.3. By Application
7.2.5.2.4. By End User
7.2.5.3. Japan
7.2.5.3.1. By Product
7.2.5.3.2. By Material
7.2.5.3.3. By Application
7.2.5.3.4. By End User
7.2.5.4. South Korea
7.2.5.4.1. By Product
7.2.5.4.2. By Material
7.2.5.4.3. By Application
7.2.5.4.4. By End User
7.2.5.5. Australia & New Zealand
7.2.5.5.1. By Product
7.2.5.5.2. By Material
7.2.5.5.3. By Application
7.2.5.5.4. By End User
7.2.5.6. Indonesia
7.2.5.6.1. By Product
7.2.5.6.2. By Material
7.2.5.6.3. By Application
7.2.5.6.4. By End User
7.2.5.7. Malaysia
7.2.5.7.1. By Product
7.2.5.7.2. By Material
7.2.5.7.3. By Application
7.2.5.7.4. By End User
7.2.5.8. Singapore
7.2.5.8.1. By Product
7.2.5.8.2. By Material
7.2.5.8.3. By Application
7.2.5.8.4. By End User
7.2.5.9. Philippines
7.2.5.9.1. By Product
7.2.5.9.2. By Material
7.2.5.9.3. By Application
7.2.5.9.4. By End User
7.2.5.9.5. By End User
7.2.5.10. Vietnam
7.2.5.10.1. By Product
7.2.5.10.2. By Material
7.2.5.10.3. By Application
7.2.5.10.4. By End User
7.2.5.11. Rest of APAC
7.2.5.11.1. By Product
7.2.5.11.2. By Material
7.2.5.11.3. By Application
7.2.5.11.4. By End User
8. Latin America Regenerative Medicine Market
8.1. Market Size & Forecast, 2019–2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Material
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.2.5.1. Brazil
8.2.5.1.1. By Product
8.2.5.1.2. By Material
8.2.5.1.3. By Application
8.2.5.1.4. By End User
8.2.5.2. Mexico
8.2.5.2.1. By Product
8.2.5.2.2. By Material
8.2.5.2.3. By Application
8.2.5.2.4. By End User
8.2.5.3. Argentina
8.2.5.3.1. By Product
8.2.5.3.2. By Material
8.2.5.3.3. By Application
8.2.5.3.4. By End User
8.2.5.4. Peru
8.2.5.4.1. By Product
8.2.5.4.2. By Material
8.2.5.4.3. By Application
8.2.5.4.4. By End User
8.2.5.5. Colombia
8.2.5.5.1. By Product
8.2.5.5.2. By Material
8.2.5.5.3. By Application
8.2.5.5.4. By End User
8.2.5.6. Rest of LATAM
8.2.5.6.1. By Product
8.2.5.6.2. By Material
8.2.5.6.3. By Application
8.2.5.6.4. By End User
9. Middle East & Africa Regenerative Medicine Market
9.1. Market Size & Forecast, 2019–2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Material
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.2.5.1. Saudi Arabia
9.2.5.1.1. By Product
9.2.5.1.2. By Material
9.2.5.1.3. By Application
9.2.5.1.4. By End User
9.2.5.2. UAE
9.2.5.2.1. By Product
9.2.5.2.2. By Material
9.2.5.2.3. By Application
9.2.5.2.4. By End User
9.2.5.3. Qatar
9.2.5.3.1. By Product
9.2.5.3.2. By Material
9.2.5.3.3. By Application
9.2.5.3.4. By End User
9.2.5.4. Kuwait
9.2.5.4.1. By Product
9.2.5.4.2. By Material
9.2.5.4.3. By Application
9.2.5.4.4. By End User
9.2.5.5. South Africa
9.2.5.5.1. By Product
9.2.5.5.2. By Material
9.2.5.5.3. By Application
9.2.5.5.4. By End User
9.2.5.6. Nigeria
9.2.5.6.1. By Product
9.2.5.6.2. By Material
9.2.5.6.3. By Application
9.2.5.6.4. By End User
9.2.5.7. Egypt
9.2.5.7.1. By Product
9.2.5.7.2. By Material
9.2.5.7.3. By Application
9.2.5.7.4. By End User
9.2.5.8. Rest of MEA
9.2.5.8.1. By Product
9.2.5.8.2. By Material
9.2.5.8.3. By Application
9.2.5.8.4. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Regenerative Medicine Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Regenerative Medicine Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Aspect Biosystems,
12.2. Amgen, Inc.,
12.3. Medtronic plc,
12.4. AstraZeneca,
12.5. Novartis AG,
12.6. Smith & Nephew plc,
12.7. MiMedx Group,
12.8. Baxter
12.9. 3M
12.10. Athersys Inc
12.11. Cryo Life Inc
12.12. Integra Life Sciences
12.13. Isto Biologics
12.14. Medtronic Plc
12.15. Organogenesis
12.16. Stryker Corporation
12.17. US Stem Cell Inc
12.18. Zimmer Biomet Holdings Inc
12.19. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations
*Financial information in case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

$4,850
$5,750
$8,150

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings